Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Kieran F, Docherty"'
Autor:
Jaclyn Carberry, Mark C. Petrie, Matthew M.Y. Lee, Katriona Brooksbank, Ross T. Campbell, Richard Good, Pardeep S. Jhund, Peter Kellman, Ninian N. Lang, Kenneth Mangion, Patrick B. Mark, Alex McConnachie, John J.V. McMurray, Barbara Meyer, Vanessa Orchard, Aadil Shaukat, Stuart Watkins, Paul Welsh, Naveed Sattar, Colin Berry, Kieran F. Docherty
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 2001-2012 (2024)
Abstract Aims Patients with a reduced left ventricular ejection fraction (LVEF) following an acute myocardial infarction (MI) are at risk of progressive adverse cardiac remodelling that can lead to the development of heart failure and death. The earl
Externí odkaz:
https://doaj.org/article/2392cabc2be74029819f96fb1ade1e0f
Autor:
Kieran F. Docherty, John J.V. McMurray, Paul R. Kalra, John G.F. Cleland, Ninian N. Lang, Mark C. Petrie, Michele Robertson, Ian Ford
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 1875-1879 (2024)
Abstract Aims To explore the potential interaction between use of SGLT2 inhibitors and the increase in haemoglobin in patients randomized to intravenous iron or the control group in the IRONMAN (Effectiveness of Intravenous Iron Treatment versus Stan
Externí odkaz:
https://doaj.org/article/7b8685721c094d3f8713fa148d206e05
Autor:
Muhammad Shahzeb Khan, MD, MSc, Khawaja M. Talha, MBBS, Muhammad Haisum Maqsood, MD, Jennifer A. Rymer, MD, MBA, Barry A. Borlaug, MD, Kieran F. Docherty, MD, Ambarish Pandey, MD, Florian Kahles, MD, Maja Cikes, MD, Carolyn S.P. Lam, MD, Anique Ducharme, MD, Adrian A. Voors, MD, Adrian F. Hernandez, MD, A. Michael Lincoff, MD, Mark C. Petrie, MD, Paul M. Ridker, MD, MPH, Marat Fudim, MD, MHS
Publikováno v:
JACC: Advances, Vol 3, Iss 8, Pp 101063- (2024)
Background: Elevated interleukin (IL)-6 levels have been linked to adverse outcomes in patients with and without baseline cardiovascular disease (CVD). Objectives: The purpose of this study was to examine the association between circulating IL-6 leve
Externí odkaz:
https://doaj.org/article/cd76b365474f441694530afc743a96f5
Autor:
João Pedro Ferreira, Brian L. Claggett, Kieran F. Docherty, Pardeep S. Jhund, Faiez Zannad, Scott D. Solomon, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 9, Iss 5, Pp 3655-3658 (2022)
Abstract Aims Data on long‐term treatment effects are scarce, despite the intent to use new therapies for many years and the need of patients, physicians and payers to have a better understanding of the lifetime benefits of treatments. The restrict
Externí odkaz:
https://doaj.org/article/d96549ef521b40958a7582c17c694329
Autor:
Caroline Espersen, Ross T. Campbell, Brian Claggett, Eldrin F. Lewis, John D. Groarke, Kieran F. Docherty, Matthew M.Y. Lee, Moritz Lindner, Tor Biering‐Sørensen, Scott D. Solomon, John J.V. McMurray, Elke Platz
Publikováno v:
ESC Heart Failure, Vol 8, Iss 3, Pp 1784-1795 (2021)
Abstract Aims We sought to examine sex differences in congestion in patients hospitalized for acute heart failure (AHF). Understanding congestive patterns in women and men with AHF may provide insights into sex differences in the presentation and pro
Externí odkaz:
https://doaj.org/article/7d5ad3d723824bfb86077ad182316123
Autor:
Kieran F. Docherty, Ross T. Campbell, Katriona J.M. Brooksbank, Rosemary L. Godeseth, Paul Forsyth, Alex McConnachie, Giles Roditi, Bethany Stanley, Paul Welsh, Pardeep S. Jhund, Mark C. Petrie, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 8, Iss 1, Pp 129-138 (2021)
Abstract Aims In patients at high risk of heart failure following myocardial infarction (MI) as a result of residual left ventricular systolic dysfunction (LVSD), the angiotensin receptor neprilysin inhibitor sacubitril/valsartan may result in a grea
Externí odkaz:
https://doaj.org/article/b4837017d41046cd93b316bf68bf6682
Autor:
Jawad H. Butt, Kieran F. Docherty, Brian L. Claggett, Akshay S. Desai, Magnus Petersson, Anna Maria Langkilde, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Lars Køber, Carolyn S. P. Lam, Felipe A. Martinez, Piotr Ponikowski, Marc S. Sabatine, Sanjiv J. Shah, Muthiah Vaduganathan, Pardeep S. Jhund, Scott D. Solomon, John J. V. McMurray
Publikováno v:
JAMA Cardiology, 8(4), 386-393. American Medical Association
ImportanceGout is common in patients with heart failure (HF), and sodium-glucose cotransporter 2 inhibitors, a foundational treatment for HF, reduce uric acid levels.ObjectiveTo examine the reported prevalence of gout at baseline, the association bet
Autor:
Jawad H. Butt, Kieran F. Docherty, Brian L. Claggett, Akshay S. Desai, James C. Fang, Magnus Petersson, Anna Maria Langkilde, Rudolf A. de Boer, Jose Walter Cabrera Honorio, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail N. Kosiborod, Lars Køber, Carolyn S.P. Lam, Felipe A. Martinez, Piotr Ponikowski, Marc S. Sabatine, Orly Vardeny, Eileen O'Meara, Jose F.K. Saraiva, Sanjiv J. Shah, Muthiah Vaduganathan, Pardeep S. Jhund, Scott D. Solomon, John J.V. McMurray
Publikováno v:
JACC: Heart Failure. 11:375-388
Background: Black people have a higher incidence and prevalence of heart failure (HF) than White people, and once HF has developed, they may have worse outcomes. There is also evidence that the response to several pharmacologic therapies may differ b
Autor:
Carly Adamson, Kieran F. Docherty, Hiddo J.L. Heerspink, Rudolf A. de Boer, Kevin Damman, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod, Felipe A. Martinez, Mark C. Petrie, Piotr Ponikowski, Marc S. Sabatine, Morten Schou, Scott D. Solomon, Subodh Verma, Olof Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Muthiah Vaduganathan, Pardeep S. Jhund, John J.V. McMurray
Publikováno v:
Adamson, C, Docherty, K F, Heerspink, H J L, De Boer, R A, Damman, K, Inzucchi, S E, Køber, L, Kosiborod, M N, Martinez, F A, Petrie, M C, Ponikowski, P, Sabatine, M S, Schou, M, Solomon, S D, Verma, S, Bengtsson, O, Langkilde, A M, Sjöstrand, M, Vaduganathan, M, Jhund, P S & McMurray, J J V 2022, ' Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction : Insights From DAPA-HF ', Circulation, vol. 146, no. 6, pp. 438-449 . https://doi.org/10.1161/CIRCULATIONAHA.121.058910
Circulation, 146(6), 438-449. LIPPINCOTT WILLIAMS & WILKINS
Circulation, 146(6), 438-449. LIPPINCOTT WILLIAMS & WILKINS
Background: In a post hoc analysis, the frequency of occurrence of an early decline (dip) in estimated glomerular filtration rate (eGFR) after initiation of dapagliflozin and its association with outcomes were evaluated in patients with heart failure
Autor:
Jawad H. Butt, Pooja Dewan, Ersilia M. DeFilippis, Tor Biering-Sørensen, Kieran F. Docherty, Pardeep S. Jhund, Mikhail N. Kosiborod, Felipe A. Martinez, Olof Bengtsson, Niklas Dyrby Johansen, Anna Maria Langkilde, Mikaela Sjöstrand, Muthiah Vaduganathan, Scott D. Solomon, Marc S. Sabatine, Lars Køber, Mona Fiuzat, John J.V. McMurray
Publikováno v:
JACC: Heart Failure. 10:543-555